Literature DB >> 1929539

Decreased specific anti-elastase activity in the uninvolved skin of patients with psoriasis.

W Glinski1, M Pierozynska-Dubowska, M Glinska-Ferenz, S Jablońska.   

Abstract

Inhibitory activities against elastase, chymotrypsin and trypsin were studied in the fluid from experimentally developed suction blisters in the uninvolved skin of patients with psoriasis. These activities determined by spectrophotometry of specific synthetic low molecular weight substrates were compared with respective antiproteinase activities in sera of 32 patients with psoriatic lesions, ten patients in remission, and ten healthy volunteers. A marked reduction (29.2%) in the specific elastase inhibitory activity of blister fluid was found in patients with psoriasis when compared with normal subjects (p less than 0.05), since neither chymotrypsin nor trypsin inhibitory activities were altered. This reduction was despite about a 30% increase in the elastase inhibitory activity in the sera of these patients, which was related presumably to their increased activity of alpha 1-proteinase inhibitor, the main serum antiserine proteinase inhibitor. A decreased blister fluid:serum elastase inhibition ratio was shown in a large majority of patients with psoriasis, even in symptomless patients. The deficiency in specific elastase inhibitory activity of suction blister fluid was predominantly associated with early onset of psoriasis, guttate lesions and inactive lesions, skin involvement less than 20% of body surface, duration of relapse shorter than 2 months, and frequent relapses. These data indicate that the uninvolved skin of patients with psoriasis contains low concentrations of specific elastase tissue inhibitor, which deficiency might result in an excessive in vivo hydrolytic activity of neutrophil elastase released from migrating cells in the psoriatic skin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1929539     DOI: 10.1007/bf01106106

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  34 in total

1.  Mapping the extended substrate binding site of cathepsin G and human leukocyte elastase. Studies with peptide substrates related to the alpha 1-protease inhibitor reactive site.

Authors:  K Nakajima; J C Powers; B M Ashe; M Zimmerman
Journal:  J Biol Chem       Date:  1979-05-25       Impact factor: 5.157

2.  Alpha 1-proteinase inhibitor in psoriasis: reduced activity in symptom-free patients and during flare.

Authors:  D Barszcz; Z Zarebska; M Glińska-Ferenz; S Jabłońska; M Tigałonowa; W Gliński
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

Review 3.  The pathomechanisms of psoriasis; the skin immune system and cyclosporin.

Authors:  J D Bos
Journal:  Br J Dermatol       Date:  1988-02       Impact factor: 9.302

Review 4.  Neutrophil granule constituents and their release in health and disease.

Authors:  L A Boxer; J E Smolen
Journal:  Hematol Oncol Clin North Am       Date:  1988-03       Impact factor: 3.722

5.  Epidermal plasminogen activator activity, tPA-dependent, is a marker of disease activity in psoriasis.

Authors:  T Lotti; P Bonan; E Panconesi
Journal:  J Invest Dermatol       Date:  1988-01       Impact factor: 8.551

6.  Evidence for an alternative pathway of keratinocyte maturation in psoriasis from an antigen found in psoriatic but not normal epidermis.

Authors:  J N Mansbridge; A M Knapp; A M Strefling
Journal:  J Invest Dermatol       Date:  1984-10       Impact factor: 8.551

7.  Uninvolved skin from psoriatic patients develops signs of involved psoriatic skin after being grafted onto nude mice.

Authors:  J E Fraki; R A Briggaman; G S Lazarus
Journal:  Science       Date:  1982-02-05       Impact factor: 47.728

8.  Stimulated release of neutral proteinases elastase and cathepsin G from inflammatory rat polymorphonuclear leukocytes.

Authors:  M A Bray; C McKearn-Smith; G Metz-Virca; J L Bodmer; G D Virca
Journal:  Inflammation       Date:  1987-03       Impact factor: 4.092

Review 9.  Prostaglandins, leukotrienes, phospholipase, platelet activating factor, and cytokines: an integrated approach to inflammation of human skin.

Authors:  M W Greaves; R D Camp
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

10.  Neutral proteinases and other neutrophil enzymes in psoriasis, and their relation to disease activity.

Authors:  W Gliński; D Barszcz; E Janczura; Z Zarebska; S Jabłońska
Journal:  Br J Dermatol       Date:  1984-08       Impact factor: 9.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.